Long-term dexmedetomidine use and safety profile among critically Ill children and neonates

Pediatric Critical Care Medicine

Volumn 15, Issue 8, 2014, Pages 706-714

  Whalen, Lesta D ^a   Di Gennaro, Jane L ^a   Irby, Gretchen A ^a   Yanay, Ofer ^a   Zimmerman, Jerry J ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Benzodiazepines; Critically ill; Dexmedetomidine; Opiates; Pediatrics; Prolonged infusion; Withdrawal

Indexed keywords

BENZODIAZEPINE; CLONIDINE; DEXMEDETOMIDINE; OPIATE; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; AGITATION; ARTICLE; CHILD; CRITICALLY ILL PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG INFUSION; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEART RATE; HEART SURGERY; HEMODYNAMICS; HUMAN; HYPERTHERMIA; HYPOTENSION; INFANT; INTENSIVE CARE UNIT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PATIENT COMFORT; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; SLEEP DISORDER; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; TREATMENT DURATION; UNIVERSITY HOSPITAL; WITHDRAWAL SYNDROME; BLOOD PRESSURE; CRITICAL ILLNESS; DRUG EFFECTS; SUBSTANCE WITHDRAWAL SYNDROME; TIME;

ADOLESCENT; ANALGESICS, OPIOID; BENZODIAZEPINES; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; DEXMEDETOMIDINE; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 84918785294     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000200     Document Type: Article

References (32)

1. Tobias JD: Dexmedetomidine: Applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 2007; 8:115-131.
2. Buck ML: Dexmedetomidine use in pediatric intensive care and procedural sedation. J Pediatr Pharmacol Ther 2010; 15:17-29.
3. Guinter JR, Kristeller JL: Prolonged infusions of dexmedetomidine in critically ill patients. Am J Health Syst Pharm 2010; 67:1246-1253.
4. Barton KP, Munoz R, Morell VO, et al: Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr Crit Care Med 2008; 9:612-615.
5. Bejian S, Valasek C, Nigro JJ, et al: Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit. Cardiology in the Young 2009; 19:98-104.
6. Berkenbosch JW: Dexmedetomidine and pediatric (cardiac) critical care-are we there yet? Pediatr Crit Care Med 2010; 11:148-149.
7. Buck ML, Willson DF: Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy 2008; 28:51-57.
8. Carroll CL, Krieger D, Campbell M, et al: Use of dexmedetomidine for sedation of children hospitalized in the intensive care unit. J Hosp Med 2008; 3:142-147.
9. Chrysostomou C, Zeballos T: Use of dexmedetomidine in a pediatric heart transplant patient. Pediatr Cardiol 2005; 26:651-654.
10. Chrysostomou C, Di Filippo S, Manrique A, et al: Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006; 7:126-131.
11. Chrysostomou C, De Toledo JS, Avolio T, et al: Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery? Pediatr Crit Care Med 2009; 10:654-660.
12. Czaja AS, Zimmerman JJ: The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med 2009; 10:381-386.
13. Diaz SM, Rodarte A, Foley J, et al: Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: Preliminary study. Pediatr Crit Care Med 2007; 8:419-424.
14. Hosokawa K, Shime N, Kato Y, et al: Dexmedetomidine sedation in children after cardiac surgery. Pediatr Crit Care Med 2010; 11:39-43.
15. Tobias JD, Berkenbosch JW: Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12:171-175.
16. Tobias JD, Berkenbosch JW, Russo P: Additional experience with dexmedetomidine in pediatric patients. South Med J 2003; 96:871-875.
17. Burbano NH, Otero AV, Berry DE, et al: Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease. Intensive Care Med 2012; 38:300-307.
18. Darnell C, Steiner J, Szmuk P, et al: Withdrawal from multiple sedative agent therapy in an infant: Is dexmedetomidine the cause or the cure? Pediatr Crit Care Med 2010; 11:e1-e3.
19. Enomoto Y, Kudo T, Saito T, et al: Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplant. Pediatr Anesth 2006; 16:1258-1288.
20. Hammer GB, Philip BM, Schroeder AR, et al: Prolonged infusion of dexmedetomidine for sedation following tracheal resection. Pediatr Anesth 2005; 15:616-620.
21. Reiter PD, Pietras M, Dobyns EL: Prolonged dexmedetomidine infusions in critically ill infants and children. Indian Pediatr 2009; 46:767-773.
22. Walker J, MacCallum M, Fischer C, et al: Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006; 27:206-210.
23. Weber MD, Thammasitboon S, Rosen DA: Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient. Paediatr Anaesth 2008; 18:87-88.
24. Deeter KH, King MA, Ridling D, et al: Successful implementation of a pediatric sedation protocol for mechanically ventilated patients. Pediatr Crit Care Med 2011; 39:683-688.
25. Franck LS, Naughton I, Winter I: Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs 2004; 20:344-351.
26. Riker RR, Shehabi Y, Bokech PM, et al: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499.
27. Shehabi Y, Ruettimann U, Adamson H, et al: Dexmedetomidine infusion for more than 24 hours in critically ill patients: Sedative and cardiovascular effects. Intensive Care Med 2004; 30:2188-2196.
28. Ruokonen E, Parviainen I, Jakob SM, et al: Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009; 35:282-290.
29. Abuhasna S, Al Jundi A, Abdelatty W, et al: Evaluation of long-term infusion of dexmedetomidine in critically ill patients: A retrospective analysis. Int J Crit Illn Inj Sci 2012; 2:70-74.
30. Pandharipande PP, Pun BT, Herr DL, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298:2644-2653.
31. Gupta P, Whiteside W, Sabati A, et al: Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease. Pediatr Crit Care Med 2012; 13:1-7.
32. Tobias JD, Berkenbosch JW: Sedation during mechanical ventilation in infants and children: Dexmedetomidine versus midazolam. South Med J 2004; 97:451-455.